Photo credit Binuri Ranasinghe
While not yet widely available in Saskatchewan, 25 doctors and pharmacists in the province have signed up for training on the use of the abortion pill Mifegymiso.
Province has not decided whether $300 dosage will be funded. The much-discussed abortion pill Mifegymiso will not be coming to Manitoba for at least a few more months.
The new abortion pill Mifegymiso will now be covered by the student health care plan, following changes approved by Campus Trust, the university’s health insurance provider.
As reproductive rights come under assault in the U.S., the story of new pregnancy-termination medication reveals continuing barriers to reproductive health for Canadian women